Press Release

Blue Charm Partners with MS Society of Canada

May 18, 2021
Return to all articles

New Partnership

Blue Charm Adherence is a healthcare company providing patients with interactive self-help platforms and behavioral modification tools that assist in increasing overall understanding of disease-related health and medication adherence.

With multiple sclerosis as Blue Charm’s first disease focus, the patient offering seeks to improve health literacy in terms of disease, treatment, and adherence, while assisting patients in accessing medications through engagement with uniquely customized programs. The organization is pleased to launch its medication adherence platform within Canada in partnership with the MS Society of Canada. As part of this partnership, the MS Society will share generated content, information, and awareness of the platform with no direct or indirect financial compensation, investment, or interest from Blue Charm, or any additional partners or third-party stakeholders.

The Blue Charm Adherence mobile application was created in accordance with patient-centric design principles, while the software engine, AdherencyRxTM, provides a level of unparalleled sophistication driven by brand strategy and the associated clinical data. Organizations offering Disease Modifying Therapies (DMTs) to people with multiple sclerosis are invited to participate in the launch which will commence in Q2, 2021.

‍
To get involved please contact:

‍
Dr. Greg Patey

Blue Charm Adherence Inc.
g.patey@bluecharm.io

Articles you might like

Insights

Empowering Patients: The Crucial Role of Education in Respiratory Disease Management

Respiratory Therapist with seven years of experience highlights the importance of patient education in managing respiratory diseases. This post reveals that a significant portion of COPD and Asthma patients receive an insufficient amount of education on medication use and disease management.
Insights

Five Insights from Blue Charm’s Respiratory Program in Partnership with the Canadian Lung Association

At Blue Charm, we hear directly from patients about the challenges they face, things they need, and impact of their medications. In today’s article we’re sharing a few insights from our asthma and COPD patients. 
Insights

The Next Frontier in Real-World Evidence: Unlocking the Patient Voice

The promise of Real-World Evidence/Data has always been to support clinical decision making with the highest possible quality of evidence. In practice, what does this actually mean and how does it enable us to provide better care for patients?